by admin | Jun 25, 2025 | News & Opinions
By Gina Kolata – New York Times – Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes. A single infusion of a stem cell-based treatment may...
by admin | Jun 24, 2025 | News & Opinions
By Eleanor Garth – Longevity.Technology – Leopoldina issues policy paper urging integration of geroscience into national healthcare and research infrastructure. Germany’s National Academy of Sciences Leopoldina has published a detailed policy paper calling...
by admin | Jun 23, 2025 | News & Opinions
By The Associated Press – PORTLAND, Ore. — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology...
by admin | Jun 20, 2025 | News & Opinions
By Vijay Kumar Malesu – Medical life Sciences News – In a recent study published in the journal Nature Communications, researchers in the United States explored how cytochrome P450 family 26 subfamily B member 1 (CYP26B1)-mediated retinoic acid (RA)...
by admin | Jun 19, 2025 | News & Opinions
by Kermit Pattison – The Harvard Gazette – Decades later, Doug Melton and team are testing treatment that could make insulin shots obsolete. Doug Melton’s life irrevocably changed the day his child was diagnosed with a life-threatening disease. But unlike...
by admin | Jun 18, 2025 | News & Opinions
By Mass General Brigham – Marcela Maus, MD, PhD, director of the Cellular Immunotherapy Program and the Paula J. O’Keeffe Endowed Chair of the Mass General Cancer Center, is senior author and Stefanie Bailey, PhD, Hana Takei, and Giulia Escobar, PhD of the...
